Showing results (1961-1970 of 2,096) with videos related to
Sort By:
Pageof 210
Journal for Immunotherapy of Cancer|August 16, 2017
The MEK inhibitor selumetinib complements CTLA-4 blockade by reprogramming the tumor immune microenvironmentEdmund Poon, Stefanie Mullins, Amanda Watkins, et al.Solar Physics|July 27, 2022
First Hard X-Ray Imaging Results by Solar Orbiter STIXPaolo Massa, Andrea F Battaglia, Anna Volpara, et al.The Laryngoscope|September 9, 2018
Predictors of gastrostomy tube dependence in surgically managed oropharyngeal squamous cell carcinomaVivek R Varma, Antoine Eskander, Stephen Y Kang, et al.Nature Catalysis|October 27, 2025
Methylthio-alkane reductases use nitrogenase metalloclusters for carbon-sulfur bond cleavageAna Lago-Maciel, Jéssica C Soares, Jan Zarzycki, et al.Nature Communications|May 28, 2021
Exploring protein hotspots by optimized fragment pharmacophoresDávid Bajusz, Warren S Wade, Grzegorz Satała, et al.Oral Oncology|March 3, 2018
Effect of adjuvant radiotherapy treatment center volume on overall survivalRamez Philips, Daniel Martin, Antoine Eskander, et al.Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|November 30, 2011
Liposuction - a surgical procedure in dermatologyStefan Rapprich, Josef Koller, Gerhard Sattler, et al.Pediatric Blood & Cancer|September 22, 2020
Treatment response of CNS high-grade neuroepithelial tumors with MN1 alterationLorena V Baroni, Carlos Rugilo, Fabiana Lubieniecki, et al.Journal of Thrombosis and Haemostasis : JTH|April 28, 2024
Variant mapping using mass spectrometry-based proteotyping as a diagnostic tool in von Willebrand diseaseIris C Kreft, Tirsa T van Duijl, Calvin van Kwawegen, et al.Molecular Pharmaceutics|December 10, 2021
Quantitative Evaluation of Dendritic Nanoparticles in Mice: Biodistribution Dynamics and Downstream Tumor Efficacy OutcomesChristina Vasalou, Douglas Ferguson, Weimin Li, et al.Pageof 210